Concurrent Investment Advisors LLC raised its stake in Morgan Stanley (NYSE:MS – Free Report) by 10.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 17,441 shares of the financial services provider’s stock after acquiring an additional 1,717 shares during the quarter. Concurrent Investment Advisors LLC’s holdings in Morgan Stanley were worth $1,818,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Advisory Alpha LLC increased its position in Morgan Stanley by 4.6% in the first quarter. Advisory Alpha LLC now owns 2,644 shares of the financial services provider’s stock worth $249,000 after buying an additional 117 shares during the last quarter. Envestnet Portfolio Solutions Inc. raised its stake in Morgan Stanley by 12.8% in the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 125,000 shares of the financial services provider’s stock valued at $11,770,000 after acquiring an additional 14,175 shares during the period. Empowered Funds LLC lifted its holdings in Morgan Stanley by 7.0% during the first quarter. Empowered Funds LLC now owns 34,982 shares of the financial services provider’s stock valued at $3,294,000 after purchasing an additional 2,278 shares during the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management boosted its position in Morgan Stanley by 23.0% during the first quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 10,172 shares of the financial services provider’s stock worth $958,000 after purchasing an additional 1,904 shares during the period. Finally, PFG Advisors increased its stake in shares of Morgan Stanley by 25.5% in the first quarter. PFG Advisors now owns 2,961 shares of the financial services provider’s stock worth $279,000 after purchasing an additional 601 shares in the last quarter. 84.19% of the stock is owned by institutional investors.
Insider Buying and Selling
In other Morgan Stanley news, Director Stephen J. Luczo sold 60,000 shares of Morgan Stanley stock in a transaction that occurred on Thursday, October 17th. The shares were sold at an average price of $119.17, for a total transaction of $7,150,200.00. Following the transaction, the director now directly owns 138,363 shares of the company’s stock, valued at approximately $16,488,718.71. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.24% of the stock is currently owned by corporate insiders.
Morgan Stanley Stock Down 2.3 %
Morgan Stanley Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Thursday, October 31st will be issued a dividend of $0.925 per share. The ex-dividend date is Thursday, October 31st. This represents a $3.70 dividend on an annualized basis and a dividend yield of 2.88%. Morgan Stanley’s dividend payout ratio is 56.32%.
Analyst Ratings Changes
MS has been the topic of a number of recent research reports. Royal Bank of Canada upped their price target on shares of Morgan Stanley from $108.00 to $122.00 and gave the company a “sector perform” rating in a research note on Thursday, October 17th. JMP Securities reaffirmed a “market perform” rating on shares of Morgan Stanley in a report on Thursday, July 18th. BMO Capital Markets lifted their price target on Morgan Stanley from $116.00 to $118.00 and gave the company an “outperform” rating in a research report on Thursday, July 18th. UBS Group increased their price objective on Morgan Stanley from $102.00 to $112.00 and gave the stock a “neutral” rating in a report on Tuesday, October 8th. Finally, HSBC raised Morgan Stanley from a “hold” rating to a “buy” rating and set a $118.00 target price for the company in a report on Friday, October 4th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $109.24.
Get Our Latest Stock Report on Morgan Stanley
About Morgan Stanley
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.
Featured Stories
- Five stocks we like better than Morgan Stanley
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- What is Insider Trading? What You Can Learn from Insider Trading
- Breakout Alert: Qualcomm Just Hit The Rally Button
- Investing In Automotive Stocks
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS – Free Report).
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.